Cannabinoids in the Management of Musculoskeletal Pain: A Critical Review of the Evidence.
作者： Kim Madden , Niek van der Hoek , Simrun Chona , Annie George , Tristiana Dalchand
DOI: 10.2106/JBJS.RVW.17.00153
关键词:
摘要:
sci-hub.se 参考文章(22)
Sunil K. Aggarwal, PhD, MD Candidate, Gregory T. Carter, MD, MS, Mark D. Sullivan, MD, PhD, Craig ZumBrunnen, PhD, Richard Morrill, PhD, Jonathan D. Mayer, PhD, Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State Journal of opioid management. ,vol. 5, pp. 257- 286 ,(2018) , 10.5055/JOM.2009.0028
Pierre Beaulieu, Effects of nabilone, a synthetic cannabinoid, on postoperative pain. Canadian Journal of Anaesthesia-journal Canadien D Anesthesie. ,vol. 53, pp. 769- 775 ,(2006) , 10.1007/BF03022793
M. Gofeld, S. Robinson, G. Faclier, Administration of nabilone for postoperative pain control in the marijuana-addicted: Case study Acute Pain. ,vol. 8, pp. 29- 32 ,(2006) , 10.1016/J.ACPAIN.2005.11.003
Iain Kinloch Crombie, Huw Talfryn Oakley Davies, William A Macrae, Cut and thrust: antecedent surgery and trauma among patients attending a chronic pain clinic Pain. ,vol. 76, pp. 167- 171 ,(1998) , 10.1016/S0304-3959(98)00038-4
B Frank, M G Serpell, J Hughes, J N S Matthews, D Kapur, Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study BMJ. ,vol. 336, pp. 199- 201 ,(2008) , 10.1136/BMJ.39429.619653.80
M. E. Lynch, Mark A. Ware, Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials Journal of Neuroimmune Pharmacology. ,vol. 10, pp. 293- 301 ,(2015) , 10.1007/S11481-015-9600-6
T. G. Kantor, M. Hopper, A study of levonantradol, a cannabinol derivative, for analgesia in post operative pain: Pain. ,vol. 11, ,(1981) , 10.1016/0304-3959(81)90248-7
Zach Walsh, Robert Callaway, Lynne Belle-Isle, Rielle Capler, Robert Kay, Philippe Lucas, Susan Holtzman, Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. International Journal of Drug Policy. ,vol. 24, pp. 511- 516 ,(2013) , 10.1016/J.DRUGPO.2013.08.010
T. Wang, J.-P. Collet, S. Shapiro, M. A. Ware, Adverse effects of medical cannabinoids: a systematic review Canadian Medical Association Journal. ,vol. 178, pp. 1669- 1678 ,(2008) , 10.1503/CMAJ.071178
Wendy Swift, Peter Gates, Paul Dillon, Survey of Australians using cannabis for medical purposes. Harm Reduction Journal. ,vol. 2, pp. 18- 18 ,(2005) , 10.1186/1477-7517-2-18